Insider record · § Dir,
10% Fairmount Funds Management LLC insider buys
Every disclosed SEC Form 4 open-market purchase by 10% Fairmount Funds Management LLC (Dir, · CBIO), with the stock's move after each filing. Disclosures are public record; returns are informational, not investment advice.
Disclosed buys
1
Total bought
$12.4M
Avg Δ7d
+12.5%
Win rate · 7d
100%
Avg Δ30d
+15.1%
Last filing
2026-07-20
Buy history
| Filed | Ticker | Company | Value | Price @ | Δ1d | Δ7d | Δ30d |
|---|---|---|---|---|---|---|---|
| 2026-07-20 | CBIO | Crescent Biopharma, Inc. | $12.4M | $15.05 | +10.6% | +12.5% | +15.1% |